Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

BioVision launches-The First And The Best Cardiolipin Assay Kit In The Market
February 2017  |  Press Releases
BioVision's Cardiolipin Assay Kit (K944-100) is a fluorometric assay that makes use of a proprietary probe that binds specifically to Cardiolipin but not with any other lipids such as to Phosphatidylcholine and Sphingomyelin, thus making it highly specific.
Read More
BioVision is excited to launch Homocysteine Assay Kit
February 2017  |  Press Releases
BioVision's Homocysteine Assay Kit allows for quantification of total homocysteine in biological fluids such as plasma and serum.
Read More
There's a better way to study p38 MAPK!
August 2016  |  Press Releases
BioVision introduces Phospho-p38 MAPK (Thr¹⁸⁰+Tyr¹⁸²) Translocation Assay Kit (Cell-Based) for research in the areas of inflammation, stress,autophagy, cell differentiation and many others.
Read More
Introducing the First non ELISA-based PSA Activity Assay Kit!
August 2016  |  Press Releases
Prostate Specific Antigen (PSA) or Kallikrein-related peptidase3, is a serine protease that proteolyses Semenogelin I and Semenogelin II in seminal fluid and thus liquefying it.
Read More
BioVision's NEW ExoPure™ Exosome Isolation Kits!
July 2016  |  Press Releases
Exosomes are small endosome derived lipid nanoparticles (50-120 nm in diameter) actively secreted by exocytosis in most living cells.
Read More
Introducing BioVision's New GeneGlide™ Transfection Reagents!
May 2016  |  Press Releases
BioVision proudly announces the launch of GeneGlideTM Transfection Reagents that are ideal for delivering nucleic acids including DNA, siRNA, miRNA to mammalian cells.
Read More
Take Your Cancer Research To Next Level With Our ELISA Kits
April 2016  |  Press Releases
BioVision offers fully-validated, accurate, and ready-to-use ELISA Kits for convenient and sensitive quantitation of various cancer and tumor related targets.
Read More
Introducing Trial Size Antibodies from BioVision: An Affordable Solution to Screen Multiple Targets!
April 2016  |  Press Releases
BioVision is releasing hundreds of best performing Trail size antibodies to meet all your early stage research needs.
Read More
Introducing BioVision's New Fabulously Active (FabAct™) Proteinase K!
January 2016  |  Press Releases
BioVision proudly announces the launch of the Molecular Bology Grade Fabulously Active FabAct™ Proteinase K (recombinant), which is the most powerful proteinase among all proteinases characterized so far.
Read More
BioVision Inc, Announces The Launch Of A Multidrug Resistance Assay Kit
January 2016  |  Press Releases
BioVision, Inc., proudly announces the launch of a Multidrug Resistance Assay Kit. The assay can be HTP adaptable and does not require special equipment.
Read More

Previous 1 2 3 4 5 6 7 8 9 10 11 Next